Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion type Assertion NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_head.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion description "[These data demonstrate that PKC? is required for a TIC phenotype in ovarian cancer, and that auranofin is an attractive therapeutic option to target deadly ovarian TICs in ovarian cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion evidence source_evidence_literature NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion SIO_000772 24174471 NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion wasDerivedFrom befree-2016 NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.
- NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_assertion wasGeneratedBy ECO_0000203 NP1123760.RAo7bo3-6nD5YHsYjPV3xETxMgf0uyB_6RjYT5SEj7SQo130_provenance.